The Comprehensive Panel Plus includes oestrone (E1), oestriol (E3) and the Estrogen Quotiant (EQ) in addition to the analytes covered by the Comprehensive Hormone Panel. EQ is a simple ratio of the cancer-protective oestrogen E3 to the proliferative oestrogens E1 and E2. The EQ provides a risk assessment of breast cancer, and other hormone-responsive cancers, with a lower number (<1.0) indicating an increased risk and a higher number (>1.0) signifying a lower risk. For maximum protection, an optimal EQ is >1.5. Unfortunately, this test is not advised for men because the research on EQ has only been carried out on women. This panel is indicated for hormonal imbalance, a history of hormone-sensitive cancers, personal or family history of autoimmune disease and PCOS.
TURNAROUND TIME: 14 WORKING DAYS
